These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25163828)

  • 1. Lifestyle and clinical factors associated with elevated C-reactive protein among newly diagnosed Type 2 diabetes mellitus patients: a cross-sectional study from the nationwide DD2 cohort.
    Svensson E; Mor A; Rungby J; Berencsi K; Nielsen JS; Stidsen JV; Friborg S; Brandslund I; Christiansen JS; Beck-Nielsen H; Sørensen HT; Thomsen RW
    BMC Endocr Disord; 2014 Aug; 14():74. PubMed ID: 25163828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modifiable clinical and lifestyle factors are associated with elevated alanine aminotransferase levels in newly diagnosed type 2 diabetes patients: results from the nationwide DD2 study.
    Mor A; Svensson E; Rungby J; Ulrichsen SP; Berencsi K; Nielsen JS; Stidsen JV; Friborg S; Brandslund I; Christiansen JS; Beck-Nielsen H; Sørensen HT; Thomsen RW
    Diabetes Metab Res Rev; 2014 Nov; 30(8):707-15. PubMed ID: 24639417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased plasma neuregulin 4 concentration is associated with increased high-sensitivity C-reactive protein in newly diagnosed type 2 diabetes mellitus patients: a cross-sectional study.
    Yan PJ; Xu Y; Wan Q; Feng J; Li H; Gao CL; Yang J; Zhong HH; Zhang ZH
    Acta Diabetol; 2017 Dec; 54(12):1091-1099. PubMed ID: 28918492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.
    Pradhan AD; Manson JE; Rifai N; Buring JE; Ridker PM
    JAMA; 2001 Jul; 286(3):327-34. PubMed ID: 11466099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early-onset type 2 diabetes: Age gradient in clinical and behavioural risk factors in 5115 persons with newly diagnosed type 2 diabetes-Results from the DD2 study.
    Bo A; Thomsen RW; Nielsen JS; Nicolaisen SK; Beck-Nielsen H; Rungby J; Sørensen HT; Hansen TK; Søndergaard J; Friborg S; Lauritzen T; Maindal HT
    Diabetes Metab Res Rev; 2018 Mar; 34(3):. PubMed ID: 29172021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated C-reactive protein is a predictor of the development of diabetes in a general Japanese population: the Hisayama Study.
    Doi Y; Kiyohara Y; Kubo M; Ninomiya T; Wakugawa Y; Yonemoto K; Iwase M; Iida M
    Diabetes Care; 2005 Oct; 28(10):2497-500. PubMed ID: 16186286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of parental history of type 2 diabetes with age, lifestyle, anthropometric factors, and clinical severity at type 2 diabetes diagnosis: results from the DD2 study.
    Svensson E; Berencsi K; Sander S; Mor A; Rungby J; Nielsen JS; Friborg S; Brandslund I; Christiansen JS; Vaag A; Beck-Nielsen H; Sørensen HT; Thomsen RW
    Diabetes Metab Res Rev; 2016 Mar; 32(3):308-15. PubMed ID: 26408959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence and predictors of elevated C-reactive protein after a coronary heart disease event.
    Munkhaugen J; Otterstad JE; Dammen T; Gjertsen E; Moum T; Husebye E; Gullestad L
    Eur J Prev Cardiol; 2018 Jun; 25(9):923-931. PubMed ID: 29635941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus.
    Streja D; Cressey P; Rabkin SW
    J Diabetes Complications; 2003; 17(3):120-7. PubMed ID: 12738395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated C-reactive protein, interleukin 6, tumor necrosis factor alpha and glycemic load associated with type 2 diabetes mellitus in rural Thais: a cross-sectional study.
    Phosat C; Panprathip P; Chumpathat N; Prangthip P; Chantratita N; Soonthornworasiri N; Puduang S; Kwanbunjan K
    BMC Endocr Disord; 2017 Jul; 17(1):44. PubMed ID: 28716139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased CRP: An extended biomarker of microvascular risk in men with type 2 diabetes.
    Hermans MP; Ahn SA; Rousseau MF
    J Diabetes Complications; 2019 Nov; 33(11):107413. PubMed ID: 31477553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Factors, Lifestyle Habits, and Possible Polyneuropathy in Early Type 2 Diabetes: A Nationwide Study of 5,249 Patients in the Danish Centre for Strategic Research in Type 2 Diabetes (DD2) Cohort.
    Christensen DH; Knudsen ST; Gylfadottir SS; Christensen LB; Nielsen JS; Beck-Nielsen H; Sørensen HT; Andersen H; Callaghan BC; Feldman EL; Finnerup NB; Jensen TS; Thomsen RW
    Diabetes Care; 2020 Jun; 43(6):1266-1275. PubMed ID: 32295810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences in adiponectin and low-grade inflammation among individuals with normal glucose tolerance, prediabetes, and type 2 diabetes.
    Saltevo J; Kautiainen H; Vanhala M
    Gend Med; 2009 Sep; 6(3):463-70. PubMed ID: 19850242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein and coronary heart disease in western Turkey.
    Onat A; Sansoy V; Yildirim B; Keleş I; Uysal O; Hergenç G
    Am J Cardiol; 2001 Sep; 88(6):601-7. PubMed ID: 11564380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998.
    Thorand B; Löwel H; Schneider A; Kolb H; Meisinger C; Fröhlich M; Koenig W
    Arch Intern Med; 2003 Jan; 163(1):93-9. PubMed ID: 12523922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein as a marker of progression of carotid atherosclerosis in subjects with type 2 diabetes mellitus.
    Pleskovič A; Letonja MŠ; Vujkovac AC; Nikolajević Starčević J; Gazdikova K; Caprnda M; Gaspar L; Kruzliak P; Petrovič D
    Vasa; 2017 May; 46(3):187-192. PubMed ID: 28218562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of C-reactive protein to features of the metabolic syndrome in normal glucose tolerant, impaired glucose tolerant, and newly diagnosed type 2 diabetic subjects.
    Guerrero-Romero F; Rodríguez-Morán M
    Diabetes Metab; 2003 Feb; 29(1):65-71. PubMed ID: 12629450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of micro- and macrovascular diabetes complications at time of type 2 diabetes diagnosis and associated clinical characteristics: A cross-sectional baseline study of 6958 patients in the Danish DD2 cohort.
    Gedebjerg A; Almdal TP; Berencsi K; Rungby J; Nielsen JS; Witte DR; Friborg S; Brandslund I; Vaag A; Beck-Nielsen H; Sørensen HT; Thomsen RW
    J Diabetes Complications; 2018 Jan; 32(1):34-40. PubMed ID: 29107454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender-specific risk factors for peripheral artery disease in a voluntary screening population.
    Hiramoto JS; Katz R; Weisman S; Conte M
    J Am Heart Assoc; 2014 Mar; 3(2):e000651. PubMed ID: 24627420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of lifestyle factors on inflammation in men and women with type 2 diabetes: results from the National Health and Nutrition Examination Survey, 1999-2004.
    Jarvandi S; Davidson NO; Jeffe DB; Schootman M
    Ann Behav Med; 2012 Dec; 44(3):399-407. PubMed ID: 22865468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.